We also found that a combination of miR-130b-3p and miR-423-5p inhibitors not only inhibited cyclin D1 but also upregulated p21, leading to cell cycle arrest and the inhibition of lung cancer growth. This evidence concerns the gene CCND1 and lung carcinoma.